# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-004379
Filing Date
2023-02-24
Accepted
2023-02-24 16:16:45
Documents
58
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | abio-20221231.htm iXBRL | 10-K | 3101572
2 | EX-23.1 | abio-ex23_1.htm | EX-23 | 4244
3 | EX-31.1 | abio-ex31_1.htm | EX-31 | 16135
4 | EX-31.2 | abio-ex31_2.htm | EX-31 | 16009
5 | EX-32.1 | abio-ex32_1.htm | EX-32 | 13717
| Complete submission text file | 0000950170-23-004379.txt |  | 7928639

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | abio-20221231_cal.xml | EX-101.CAL | 39440
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | abio-20221231_pre.xml | EX-101.PRE | 268708
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | abio-20221231_lab.xml | EX-101.LAB | 403645
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | abio-20221231.xsd | EX-101.SCH | 36211
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | abio-20221231_def.xml | EX-101.DEF | 114296
52 | EXTRACTED XBRL INSTANCE DOCUMENT | abio-20221231_htm.xml | XML | 1082130

Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 23667512
SIC: 2835 In Vitro & In Vivo Diagnostic Substances